// App-Quantinova.ai

TPS4152 : Phase II trial of docetaxel and ramucirumab combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer (HGCSG1903).

Researchers

Presenter

  • Rika Saito

Principal Investigators

  • Satoshi Yuki

  • Susumu Sogabe

  • Masayoshi Dazai

  • Ayumu Hosokawa

  • Kentaro Sawada

  • Atsushi Sato

  • Michio Nakamura

  • Kazuteru Hatanaka

  • Atsushi Ishiguro

  • Osamu Muto

  • Yoshiaki Shindo

  • Yasushi Tsuji

  • Miki Tateyama

  • Akira Ueda

  • Takahide Sasaki

  • Masaki Katagiri

  • Naoya Sakamoto

  • Yoshito Komatsu

Medical Centers

  • Cancer Center, Hokkaido University Hospital, Sapporo, Japan

  • Department of Gastroenterology and Hepatology, Hokkaido University Hospital, japan, Sapporo, Japan

  • Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan

  • Department of Gastroenterology, Sapporo Medical Center NTT EC, Sapporo, Japan

  • Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan

  • Department of Medical Oncology, Kushiro Rosai Hospital, Kushiro, Japan

  • Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

  • Department of Medical Oncology,Osaki Citizen Hospital, Osaki-Shi, Japan

  • Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan

  • Department of Medical Oncology, Keiyukai Sapporo Hospital, Sapporo, Japan

  • Department of Medical Oncology, Japanese Red Cross Akita Hospital, Akita, Japan

  • Department of Gastroenterological Surgery, Nakadori General Hospital, Akita, Japan

  • Department of Medical Oncology, Keiyukai Sapporo Hospital, Sapporo, Japan

  • Department of Internal Medicine, Tomakomai Nisshou Hospital, Tomakomai, Japan

  • Department of Oncology, Toyama Red Cross Hospital, Toyama, Japan

  • Department of Internal Medicine, Hokkaido Gastroenterology Hospital, Sapporo, Japan

  • Department of Gastroenterology, Sapporo Hokuyu Hospital, Sapporo, Japan

  • Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Ramucirumab

  • Paclitaxel

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

  • Single Arm

  • Multicenteric

  • Prospective

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved